文献速递胸部肿瘤头颈与中枢神经肿瘤

预防性全脑照射后脑白质病变:海马保护与否的纵向MRI分析

Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis.
PubMed 文献 · Eur J Cancer · 2019-12-06

本研究对比小细胞肺癌患者接受海马保护(HA-PCI)与非海马保护(non-HA-PCI)预防性全脑照射后脑白质病变的风险,每组各9例并年龄匹配。结果显示HA-PCI组治疗后Fazekas评分中位1分,non-HA-PCI组中位2分(p=0.007);HA-PCI组Fazekas评分随时间显著增加(p=0.001),non-HA-PCI组无显著增加。结论认为HA-PCI后影像学改变更明显,需前瞻性长期神经认知研究后再常规应用。

要点

  • HA-PCI组治疗后Fazekas评分中位1分,显著低于non-HA-PCI组的2分(p=0.007)。
  • HA-PCI组Fazekas评分随时间显著增加(p=0.001),non-HA-PCI组无显著增加。
  • HA-PCI组Dmax及接受>25Gy的脑体积更高,但两组脑结构体积无显著差异。

核心结论

  • HA-PCI后影像学脑白质病变较non-HA-PCI更明显,Fazekas评分显著升高,预计可能干扰神经认知功能。
  • 在HA-PCI常规临床实施前,需开展前瞻性长期神经认知研究。

研究设计与样本

  • 回顾性纵向MRI分析,纳入接受PCI的小细胞肺癌患者,non-HA-PCI组9例,HA-PCI组9例,两组年龄匹配。
  • 分析放疗前及放疗后随访MRI的Fazekas评分,并分割双侧皮层及皮层下脑结构,分析剂量学参数和体积变化。

主要发现

  • 基线时两组Fazekas评分无显著差异。
  • 治疗后Fazekas评分在HA-PCI组中位为1,non-HA-PCI组中位为2,差异有统计学意义(p=0.007)。
  • HA-PCI组放疗后Fazekas评分随时间显著增加(p=0.001),non-HA-PCI组无显著增加。
  • HA-PCI组Dmax和接受>25Gy的脑体积更高。
  • 两组分割脑结构的体积无显著差异。

关键数值与推荐

  • Fazekas评分用于评估脑白质病变。
  • HA-PCI组治疗后Fazekas评分中位1分,non-HA-PCI组中位2分(p=0.007)。
  • HA-PCI组Fazekas评分随时间显著增加(p=0.001)。

临床怎么用

  • HA-PCI后脑白质病变影像学改变较non-HA-PCI更明显,临床决策时应权衡神经认知保护与影像学改变风险。
  • 目前不建议将HA-PCI作为常规临床实践,需等待前瞻性长期神经认知研究结果。

局限性

  • 样本量小,HA-PCI组和non-HA-PCI组各9例。
  • 未进行标准化神经认知测试。
  • 为回顾性分析,需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Neurocognitive changes are well described after prophylactic or therapeutic whole-brain radiotherapy (WBRT) and have been reported as early as 3 months after radiotherapy (RT). Therefore, WBRT with protection of the hippocampal region (hippocampal avoidance, HA) has been proposed to preserve neurocognition. Our aim was to compare the risk of leukoencephalopathy after prophylactic cranial irradiation (PCI) with or without HA. METHODS: Patients with small-cell lung cancer who received either lateral-opposed field PCI (non-HA-PCI; n = 9) or hippocampus avoidance PCI (HA-PCI; n = 9) with available magnetic resonance imaging (MRI) follow-up were identified and age matched. Pre-therapeutic and follow-up MRI after RT was analysed for leukoencephalopathy based on the Fazekas score. Bilateral cortical and subcortical brain structures were segmented and analysed for alterations in dosimetric parameters and volumes. RESULTS: There was no significant difference of Fazekas scores between groups at baseline. Fazekas score differed in post-treatment with a median of 1 in the HA-PCI group and 2 in the non-HA-PCI group (p = 0.007). Significant increase of Fazekas score over time after RT was observed for HA-PCI patients (p = 0.001) but not for non-HA-PCI patients. Dmax (highest radiation dose) and brain volume receiving doses >25Gy were higher in HA-PCI patients. There were no significant volumetric differences for segmented brain structures between groups. CONCLUSION: Radiological changes are more prominent after HA-PCI than after non-HA-PCI. Although no standardised neurocognitive testing was performed, the significantly increased Fazekas scores after HA-PCI are expected to interfere with neurocognitive function. Prospective long-term neurocognitive studies are warranted before HA-PCI is implemented in routine clinical practice.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Mayinger M, Kraft J, Lohaus N, et al. Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. Eur J Cancer. 2019. PMID: 31812935. doi:10.1016/j.ejca.2019.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。